Long Islanders suffering from sleep apnea inundated the sleep center at St. Charles Hospital in Port Jefferson with phone calls earlier this year after the Food and Drug Administration approved ...

Is there anything as draining (and uniquely frustrating) as chronically poor sleep? For the 30 million Americans who live with sleep apnea, disrupted sleep can be an unfortunate fact of life, making ...

A very common medical condition globally, sleep apnea is a disorder that interrupts breathing during sleep. Several factors can cause it, though the risk rises sharply with obesity because extra fat ...

Add Yahoo as a preferred source to see more of our stories on Google. GLP-1 receptor agonist drugs like Ozempic, Wegovy and Mounjaro have helped millions of Americans lose weight and better manage ...

The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA). On Dec. 20, the FDA announced that the agency has approved Eli Lilly’s Zepbound ...

(HealthDay)—A small amount of weight loss might help combat sleep apnea, a new study suggests. Finnish researchers said losing as little as 5 percent of body weight seems to lead to significant ...

Use of the new drug "resulted in significant weight reduction," according to a clinical trial from Eli Lilly.

The FDA also recommends that prescribed users reduce their caloric intake and increase their exercise Shelby Knowles/Bloomberg via Getty The weight loss drug Zepbound, generically known as tirzepatide ...

Joensuu, Finland – Sustaining a moderate amount of weight loss could help prevent the progression of obstructive sleep apnea – or even eliminate it, indicates a new study from the University of ...

Add Yahoo as a preferred source to see more of our stories on Google. The Food and Drug Administration has approved Zepbound, a GLP-1 weight-loss drug from Eli Lilly & Co., for the treatment of ...

Dec. 21 (UPI) --Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has been approved by the Food and Drug Administration for treating moderate to severe obstructive sleep apnea. The agency ...

The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the weight-loss drug Zepbound. The medicine, part of the class known as GLP-1 ...